PureTech Health plc (NASDAQ:PRTC - Get Free Report) shares saw unusually-strong trading volume on Wednesday . Approximately 2,701 shares were traded during trading, a decline of 40% from the previous session's volume of 4,480 shares.The stock last traded at $27.85 and had previously closed at $27.84.
PureTech Health Stock Performance
The firm has a 50 day moving average price of $25.98 and a 200-day moving average price of $23.38.
Institutional Inflows and Outflows
An institutional investor recently bought a new position in PureTech Health stock. Jane Street Group LLC bought a new stake in PureTech Health plc (NASDAQ:PRTC - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 8,343 shares of the company's stock, valued at approximately $269,000. Institutional investors own 0.04% of the company's stock.
PureTech Health Company Profile
(
Get Free Report)
PureTech Health plc, a clinical stage biotherapeutics company, engages in the discovery, development, and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, currently under Phase 3 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, to inhibit the activity of galectin-9 for treating solid tumors and hematological malignancies.
See Also
Before you consider PureTech Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and PureTech Health wasn't on the list.
While PureTech Health currently has a "hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
